Sfoglia per AUTORE
CREA E
Collezione ASL Asti

  

Items : 3

Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group. in Hematological oncology / Hematol Oncol. 2021 Aug;39(3):326-335. doi: 10.1002/hon.2861. Epub 2021 Mar 26.

2021
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria
AOU Novara

Cuneo A; Foà R; Marchetti M; Gentile M; Vignetti M; Mauro FR; Crea E; Marasca R; Laurenti L; Molinari AL; Pietrasanta D; Quaglia FM; Sportoletti P; Paolini R; Varettoni M; Gaidano G; Murru R; Vitagliano O; Coscia M; Farina L; Cibien F; Zamprogna G; Arena V; Visentin A; Reda G; Cavazzini F; Piciocchi A; Montillo M; Rigolin GM; et alii...

Efficacy and safety of front-line treatment with ibrutinib and rituximab in unfit patients with chronic lymphocytic leukemia (CLL). First report of the GIMEMA LLC1114 study in Haematologica

2019
ASL Asti
AO Ordine Mauriziano

Mauro FR; Molica S; Paoloni F; Reda G; Trentin L; Marchetti M; Pietrasanta D; Coscia M; Marasca R; Sportoletti P; Gaidano G; Orsucci L; Stelitano C; Di Renzo N; Liberati M; Gottardi D; Re F; Ilariucci F; Zinzani PL; Mannina D; Gozzetti A; Molinari AL; Gentile M; Chiarenza A; Laurenti L; Varettoni M; Ibatici A; Murru R; Tani M; et alii...

Ibrutinib and rituximab as front-line treatment for unfit patients with chronic lymphocytic leukemia (CLL). preliminary results from the Gimema LLC1114 study in HemaSphere

2019
AO Ordine Mauriziano
ASL Asti

Mauro FR; Molica S; Paoloni F; Reda G; Trentin L; Marchetti M; Pietrasanta D; Coscia M; Marasca R; Sportoletti P; Gaidano G; Orsucci L; Stelitano C; Di Renzo N; Liberati AM; Gottardi D; Re F; Ilariucci F; Zinzani P; Mannina D; Gozzetti A; Molinari AL; Gentile M; Consoli U; Laurenti L; Arcaini L; Ibatici A; Murru R; Tani M; et alii...